Job Description:
• Serve as the operational lead for global Phase 3 asthma studies
• Develop overall study strategy, timelines, and operational plans
• Lead scenario planning, risk assessment, and proactive mitigation efforts
• Review and approve key trial documents
• Lead and coordinate multidisciplinary study teams
• Act as the central point of accountability across stakeholders
• Enable effective communication, decision-making, and timely issue escalation
• Oversee study start-up, site identification, enrollment strategy, monitoring plans
• Ensure study conduct follows ICH-GCP, SOPs, and global regulatory requirements
• Manage study budget, vendor performance, timelines, and quality metrics
• Assist in audit preparation and ensure corrective and preventive actions
• Partner closely with data management and biostatistics for data quality
• Drive inspection readiness and continuous study health assessments
• Provide operational oversight of CROs and ensure deliverables meet expectations
Requirements:
• 8–12+ years of clinical operations experience
• At least 6 years of direct leadership in Late Phase global studies
• Late Phase Respiratory or immunology therapeutic area experience
• Strong leadership, strategic planning, communication, and problem-solving skills
• Ability to work independently while orchestrating complex cross-functional execution
• Pharmaceutical industry experience and working knowledge of ICH/GCP regulations
• Bachelor's degree required; advanced degree (MS, MPH, PharmD, PhD) preferred.
Benefits:
• Competitive benefits package
• Annual bonus
• Equity compensation
Apply Now
Apply Now